Nasal staph bacteria in patients with staph bloodstream infection
Part of Infections clinical trials.
This trial studies the bacteria living in the nose of patients with a staph bloodstream infection. It aims to better understand why some infections persist, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a bloodstream infection caused by staph bacteria.
- You have health insurance or are entitled to social security.
- You haven't been on antibiotics for this infection for more than 5 days.
- You haven't had a nasal decolonization treatment for staph in the past year.
- You are not pregnant or breastfeeding.
- Your bloodstream infection is only staph, not mixed with other bacteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new nose spray called HY-133 to see if it's safe and can clear a common type of staph bacteria from the nose. It is for people who have this bacteria but not the antibiotic-resistant kind.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
This trial tests whether switching from IV antibiotics to oral antibiotics after 3–7 days is safe and effective for people with uncomplicated Staphylococcus aureus bloodstream infections. It may help you avoid a longer hospital stay and reduce IV-related complications.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This study looks at how antibiotics affect MRSA (a type of staph infection) in the noses of hospitalized children. It may help doctors better understand MRSA to improve treatment.
This study looks at different types of Staph aureus blood infections to understand which ones are more likely to cause severe illness or death. It may help doctors predict who needs more aggressive treatment.
Hear when a new Bacteria Infection Mechanism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.